North America PARP Inhibitor Biomarkers Testing Product Market Report Covering Emerging Trends Through 2034
The North America PARP Inhibitor Biomarkers Testing Product Market is experiencing significant growth, driven by the increasing adoption of precision oncology, rising prevalence of BRCA-mutated cancers, and expanding use of companion diagnostic testing. The region benefits from advanced molecular diagnostic infrastructure, strong reimbursement frameworks, and continuous investments...
0 Commenti 0 condivisioni 46 Views 0 Anteprima